- Home
- BOX vs DYN Comparison
BOX vs DYN Comparison
Compare BOX & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BOX | DYN |
|---|---|---|
| Founded | 2005 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.0B |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BOX | DYN |
|---|---|---|
| Price | $24.64 | $17.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 14 |
| Target Price | $35.57 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 2.4M | 2.3M |
| Earning Date | 03-03-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.58 | N/A |
| Revenue | ★ $506,142,000.00 | N/A |
| Revenue This Year | $9.41 | N/A |
| Revenue Next Year | $8.15 | N/A |
| P/E Ratio | $42.51 | ★ N/A |
| Revenue Growth | ★ 26.98 | N/A |
| 52 Week Low | $21.61 | $7.01 |
| 52 Week High | $38.80 | $25.00 |
Technical Indicators
Market Signals| Indicator | BOX | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 49.56 | 54.27 |
| Support Level | $23.70 | $16.34 |
| Resistance Level | $33.30 | $20.08 |
| Average True Range (ATR) | 0.77 | 1.18 |
| MACD | 0.05 | 0.12 |
| Stochastic Oscillator | 29.13 | 63.88 |
Price Performance
Historical ComparisonAbout BOX Box Inc.
Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.